Inivata
Business Services · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7020 Kit Creek Rd Ste 140, Durham, North...Phone Number
(919) 679-2848Website
www.inivata.comRevenue
$16.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Inivata
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists. The company was founded in 2014 and is headquartered in Morrisville, North Carolina.Explore more
Inivata Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inivata your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Inivata launches new products
Funding: Get notified immidiatlly once Inivata has new funding data
Check if Inivata has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Inivata recently announced quarterly report
Check out if Inivata is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Inivata
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Inivata, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Inivata had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Inivata
Compare insights from companies similar to Inivata, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$22.2M
51-200
Private
$10M
2015
AD
Alicia DillardAssociate Clinical Laboratory Director and Molecular Pathologist
Company Profile Activity
Activity Insights
Inivata is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inivata is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inivata.
Inivata financials insights
Gather financial insights about Inivata, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Angel/Seed
$6.5M
2016
Series A
$45M
2020
Corporate Investment
$25M
2021
Series B
$60M
Inivata Tech Stack
A closer look at the technologies used by Inivata
See more technologies
Most Recent Scoops
Open Position
Open Position
Left Company
Executive Move
Inivata has announced that Charlie Kesinger, Chief Information Officer, has left the organization to join X-Chem, Inc as Chief Information Officer.
New Hire
Executive Move
Michelle Anderson has joined the organization as Senior Director, Human Resources.
Executive Moves, New Hire
Open Position
Inivata News & Media
NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022
NeoGenomics, Inc. (NASDAQ:NEO),a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announces that its liquid biopsy focused subsidiary Inivata Limited ("Inivata"), alongside collaborators, will present new data on its RaDaR™ assay for the detection of minimal residual disease (MRD) and recurrence at the European Society for Medical Oncology (ESMO) Congress, taking place September 9th-13th,Inivata and Collaborators Announce New Data Demonstrating Clinical Potential of its RaDaR™ MRD Test in HR+ HER2- Breast Cancer
Inivata and Collaborators Announce New Data Demonstrating Clinical Potential of its RaDaR™ MRD Test in HR+ HER2- Breast CancerInivata and Collaborators to Present New Data Further Validating the Application of its RaDaR® MRD and InVisionFirst®-Lung Tests at the 2022 ASCO Annual Meeting
Inivata and Collaborators to Present New Data Further Validating the Application of its RaDaR® MRD and InVisionFirst®-Lung Tests at the 2022 ASCO Annual MeetingNeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer
Study further highlights potential of RaDaR to stratify patients and improve treatment outcomesFT. MYERS, FL / ACCESSWIRE / March 17, 2022 / NeoGenomics, Inc.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Inivata
Sign Up For FreeTo access detailed company insights
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists. The company was founded in 2014 and is headquartered in Morrisville, North Carolina.... Read More
